Literature DB >> 35435729

Class C β-Lactamases: Molecular Characteristics.

Alain Philippon1, Guillaume Arlet2, Roger Labia3, Bogdan I Iorga4.   

Abstract

Class C β-lactamases or cephalosporinases can be classified into two functional groups (1, 1e) with considerable molecular variability (≤20% sequence identity). These enzymes are mostly encoded by chromosomal and inducible genes and are widespread among bacteria, including Proteobacteria in particular. Molecular identification is based principally on three catalytic motifs (64SXSK, 150YXN, 315KTG), but more than 70 conserved amino-acid residues (≥90%) have been identified, many close to these catalytic motifs. Nevertheless, the identification of a tiny, phylogenetically distant cluster (including enzymes from the genera Legionella, Bradyrhizobium, and Parachlamydia) has raised questions about the possible existence of a C2 subclass of β-lactamases, previously identified as serine hydrolases. In a context of the clinical emergence of extended-spectrum AmpC β-lactamases (ESACs), the genetic modifications observed in vivo and in vitro (point mutations, insertions, or deletions) during the evolution of these enzymes have mostly involved the Ω- and H-10/R2-loops, which vary considerably between genera, and, in some cases, the conserved triplet 150YXN. Furthermore, the conserved deletion of several amino-acid residues in opportunistic pathogenic species of Acinetobacter, such as A. baumannii, A. calcoaceticus, A. pittii and A. nosocomialis (deletion of residues 304-306), and in Hafnia alvei and H. paralvei (deletion of residues 289-290), provides support for the notion of natural ESACs. The emergence of higher levels of resistance to β-lactams, including carbapenems, and to inhibitors such as avibactam is a reality, as the enzymes responsible are subject to complex regulation encompassing several other genes (ampR, ampD, ampG, etc.). Combinations of resistance mechanisms may therefore be at work, including overproduction or change in permeability, with the loss of porins and/or activation of efflux systems.

Entities:  

Keywords:  AmpC β-lactamases; ESAC; cephalosporinases; extended-spectrum; phylogeny; primary structure

Mesh:

Substances:

Year:  2022        PMID: 35435729      PMCID: PMC9491196          DOI: 10.1128/cmr.00150-21

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   50.129


  397 in total

1.  Inducible AmpC beta-lactamase of a new member Enterobacteriaceae.

Authors:  Richard Bonnet; Catherine Chanal; Elisabeth Ageron; Danielle Sirot; Christophe De Champs; Patrick Grimont; Jacques Sirot
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.

Authors:  Amber J Schmidtke; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Isolation and characterization of cold-active family VIII esterases from an arctic soil metagenome.

Authors:  Eun Young Yu; Min-A Kwon; Miae Lee; Joon Young Oh; Ji-Eun Choi; Ji Young Lee; Bong-Keun Song; Dae-Hyun Hahm; Jae Kwang Song
Journal:  Appl Microbiol Biotechnol       Date:  2011-02-12       Impact factor: 4.813

4.  In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.

Authors:  João Pires; Magdalena Taracila; Christopher R Bethel; Yohei Doi; Sara Kasraian; Regula Tinguely; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

5.  Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution.

Authors:  Jun Yatsuyanagi; Shioko Saito; Takayuki Konno; Seizaburo Harata; Noriyuki Suzuki; Jun Kato; Ken-ichi Amano
Journal:  Jpn J Infect Dis       Date:  2006-06       Impact factor: 1.362

6.  Enzymes from cold-adapted microorganisms. The class C beta-lactamase from the antarctic psychrophile Psychrobacter immobilis A5.

Authors:  G Feller; Z Zekhnini; J Lamotte-Brasseur; C Gerday
Journal:  Eur J Biochem       Date:  1997-02-15

7.  Structural analysis of the Asn152Gly mutant of P99 cephalosporinase.

Authors:  James F Ruble; Scott T Lefurgy; Virginia W Cornish; Rachel A Powers
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-08-18

Review 8.  Interplay between β-lactamases and new β-lactamase inhibitors.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Nat Rev Microbiol       Date:  2019-05       Impact factor: 60.633

9.  Interconnected microbiomes and resistomes in low-income human habitats.

Authors:  Erica C Pehrsson; Pablo Tsukayama; Sanket Patel; Melissa Mejía-Bautista; Giordano Sosa-Soto; Karla M Navarrete; Maritza Calderon; Lilia Cabrera; William Hoyos-Arango; M Teresita Bertoli; Douglas E Berg; Robert H Gilman; Gautam Dantas
Journal:  Nature       Date:  2016-05-12       Impact factor: 49.962

10.  In silico serine β-lactamases analysis reveals a huge potential resistome in environmental and pathogenic species.

Authors:  Christian Brandt; Sascha D Braun; Claudia Stein; Peter Slickers; Ralf Ehricht; Mathias W Pletz; Oliwia Makarewicz
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.